|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,901 JPY | +1.32% |
|
-2.32% | -16.32% |
| Apr. 01 | Cogstate Amends License Agreement with Eisai for Alzheimer’s Treatment | MT |
| Apr. 01 | BioArctic, Eisai Seek US FDA Approval for Maintenance Dose of Alzheimer’s Disease Drug | MT |
(Reuters) - Japanese pharmaceutical company Eisai Co Ltd said it would cut about 25 percent, or about 450 jobs, in the United States as part of a realignment to create a more efficient and focused company.
The company's U.S. unit Eisai Inc employs about 1,800 people in the United States, according to its website, across operations such as research and development, manufacturing, sales and administration.
Eisai does not have plans to close any of its main offices or facilities in the United States, it said in a statement.
(Reporting by Rosmi Shaji in Bengaluru; Editing by Savio D'Souza)
| 1st Jan change | Capi. | |
|---|---|---|
| -16.32% | 10.8B | |
| +27.97% | 672B | |
| +24.14% | 550B | |
| -7.02% | 351B | |
| +14.85% | 317B | |
| +6.25% | 292B | |
| +2.96% | 211B | |
| -0.41% | 203B | |
| -10.02% | 194B | |
| -11.81% | 144B |
EISAI CO., LTD. 
